Prilosec OTC

Manufacturer
Physicians Total Care, Inc.
Effective date
2011-06-20
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:29:47

Label at a glance#

ProductPrilosec OTC
Active ingredientomeprazole magnesium
Label structure11 sections

Dosage and administration

for adults 18 years of age and older this product is to be used once a day (every 24 hours), every day for 14 days it may take 1 to 4 days for full effect; some people get complete relief of symptoms within 24 hours 14-Day Course of Treatment swallow 1 tablet with a glass of water before eating in the morning take every day for 14 days do not take more than 1 tablet a day do not use for more than 14 days unless di...

Storage and handling

read the directions and warnings before use keep the carton. It contains important information. store at 20-25°C (68-77°F) and protect from moisture

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Omeprazole magnesium delayed-release tablet 20.6 mg (equivalent to 20 mg omeprazole).

Purpose

OTC - PURPOSE SECTION

Acid reducer

Use

INDICATIONS & USAGE SECTION

  • treats frequent heartburn (occurs 2 or more days a week)
  • not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect

Warnings

WARNINGS SECTION

Allergy alert

SPL UNCLASSIFIED SECTION

Do not use if you are allergic to omeprazole

OTC - DO NOT USE SECTION

Do not use if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.
These may be signs of a serious condition. See your doctor.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

  • had heartburn over 3 months.
    This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating or dizziness
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking

  • warfarin, clopidogrel, or cilostazol (blood-thinning medicines)
  • prescription antifungal or anti-yeast medicines
  • diazepam (anxiety medicine)
  • digoxin (heart medicine)
  • tacrolimus (immune system medicine)
  • prescription antiretrovirals (medicines for HIV infection)

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days
  • you need to take more than 1 course of treatment every 4 months

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • for adults 18 years of age and older
  • this product is to be used once a day (every 24 hours), every day for 14 days
  • it may take 1 to 4 days for full effect; some people get complete relief of symptoms within 24 hours
    14-Day Course of Treatment
    • swallow 1 tablet with a glass of water before eating in the morning
    • take every day for 14 days
    • do not take more than 1 tablet a day
    • do not use for more than 14 days unless directed by your doctor
    • swallow whole. Do not chew or crush tablets.
    Repeated 14-Day Courses (if needed)
    • you may repeat a 14-day course every 4 months
    • do not take for more than 14 days or more often than every 4 months unless directed by a doctor
  • children under 18 years of age: ask a doctor. Heartburn in children may sometimes be caused by a serious condition.

Other information

STORAGE AND HANDLING SECTION

  • read the directions and warnings before use
  • keep the carton. It contains important information.
  • store at 20-25°C (68-77°F) and protect from moisture

Inactive ingredients

INACTIVE INGREDIENT SECTION

glyceryl monostearate, hydroxypropyl cellulose, hypromellose, iron oxide, magnesium stearate, methacrylic acid copolymer, microcrystalline cellulose, paraffin, polyethylene glycol 6000, polysorbate 80, polyvinylpyrrolidone, sodium stearyl fumarate, starch, sucrose, talc, titanium dioxide, triethyl citrate

Questions?

OTC - QUESTIONS SECTION

1-800-289-9181

SPL UNCLASSIFIED SECTION

Dist. by Procter & Gamble, Cincinnati, OH 45202

Product of Sweden

Relabeling "Additional Bar Code Label" by:
Physicians Total Care, Inc.
Tulsa, OK       74146

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 54868-5309-0

Prilosec
OTC®
omeprazole magnesium delayed-
release tablets 20.6 mg / acid reducer

42 TABLETS

Treats FREQUENT Heartburn!
Occurring
2 Or More Days A Week

PRINCIPAL DISPLAY PANEL - 14 Tablet Carton
PRINCIPAL DISPLAY PANEL - 14 Tablet Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
402014omeprazole 20 MG Delayed Release Oral TabletPSN1
608796PriLOSEC OTC 20 MG Delayed Release Oral TabletPSN1
608796omeprazole 20 MG Delayed Release Oral Tablet [Prilosec]SBD1
402014omeprazole 20 MG Delayed Release Oral TabletSCD1
402014omeprazole 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral TabletSY1
608796Prilosec 20 MG (as omeprazole magnesium 20.6 MG) Delayed Release Oral TabletSY1
608796Prilosec OTC 20 MG Delayed Release Oral TabletSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
OMEPRAZOLE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
873ef493-6b37-49d8-ac7f-bfca4117d2c1Product name520210607
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
f33561b9-47cb-411c-a228-16c62e346cd4Product name120200415
ade821ba-260a-47e2-bd89-743e27ac9906Product name120161121
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
54868-5309-02019-09-24C16284748780-19350213a-429e-c013-e053-90daa90a1393Prilosec OTC ® omeprazole magnesium delayed- release tablets 20.6 mg / acid reducer

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
54868-5309-0Prilosec OTC3 in 1 CARTONTABLET, DELAYED RELEASE31
54868-5309-0Prilosec OTC1 in 1 CARTONTABLET, DELAYED RELEASE11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
54868-5309PRILOSEC OTC (OMEPRAZOLE MAGNESIUM) TABLET, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.]12 package rows20111019_6ceb26ec-7ae4-45d5-96d1-82439273613b.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
54868-5309-0EA - Each54868-53093cdeaee7-fce3-4a58-a931-16e7ba88fff312012-07-24
37000-455-02EA - Each37000-45583d26bbf-1b1f-4662-839b-27147bd01cd912012-07-24
37000-455-03EA - Each37000-455f89a1e94-a00b-423d-bf01-2f9fc14a259b12012-07-24
37000-455-04EA - Each37000-45532829c14-995e-4463-9139-48bea577867e12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
omeprazole magnesiumACTIVE INGREDIENT426QFE7XLK1
omeprazoleACTIVE MOIETYKG60484QX91
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U1
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G6751
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE41
HYDROXYPROPYL CELLULOSEINACTIVE INGREDIENTRFW2ET671P1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WO1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I301
PARAFFININACTIVE INGREDIENTI9O0E3H2ZE1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WE1
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8H1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UI1
SUCROSEINACTIVE INGREDIENTC151H8M5541
TALCINACTIVE INGREDIENT7SEV7J4R1U1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP1
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UM1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
54868-530954868-5309-0
37000-455

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 14 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
HYDROXYPROPYL CELLULOSEHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PTABLET, DELAYED RELEASE / ORAL450 mgExact identifier — unii+route+dosage form
SUCROSESUCROSEC151H8M554TABLET, DELAYED RELEASE / ORAL295.33 mgExact identifier — unii+route+dosage form
TRIETHYL CITRATETRIETHYL CITRATE8Z96QXD6UMTABLET, DELAYED RELEASE / ORAL120 mgExact identifier — unii+route+dosage form
PARAFFINPARAFFINI9O0E3H2ZETABLET, DELAYED RELEASE / ORAL0.2 mgExact identifier — unii+route+dosage form
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, DELAYED RELEASE / ORAL144 mgExact identifier — unii+route+dosage form
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, DELAYED RELEASE / ORAL66 mgExact identifier — unii+route+dosage form
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOTABLET, DELAYED RELEASE / ORAL79 mgExact identifier — unii+route+dosage form
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HTABLET, DELAYED RELEASE / ORAL4 mgExact identifier — unii+route+dosage form
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET, DELAYED RELEASE / ORAL6 mgExact identifier — unii+route+dosage form
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, DELAYED RELEASE / ORAL37 mgExact identifier — unii+route+dosage form
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, DELAYED RELEASE / ORAL2210 mgExact identifier — unii+route+dosage form
SODIUM STEARYL FUMARATESODIUM STEARYL FUMARATE7CV7WJK4UITABLET, DELAYED RELEASE / ORAL216 mgExact identifier — unii+route+dosage form
POLYETHYLENE GLYCOL 6000POLYETHYLENE GLYCOL 600030IQX730WETABLET, DELAYED RELEASE / ORAL120 mgExact identifier — unii+route+dosage form
TALCTALC7SEV7J4R1UTABLET, DELAYED RELEASE / ORAL349 mgExact identifier — unii+route+dosage form

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021229-001PRILOSEC OTCOMEPRAZOLE MAGNESIUMEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD2003-06-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD2003-06-20d4dbc9d85df4…
2026-10-15 13:18:302026-09N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD2003-06-20c2088c7a36db…
2026-09-14 22:38:342026-08N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-2084e616aacf4f…
2026-08-18 06:07:402026-07N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-2031067a03dcf5…
2025-08-23 18:47 UTC2025-08N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-206a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-2003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-202680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-205bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-2079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-201e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-208072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-205c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-205d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-204b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-2074a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-2087673890dc5c…
2021-03-12 10:30 UTC2021-03N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-205aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-208869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-203f01610625f2…
2019-09-15 20:21 UTC2019-09N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20b00525d2431f…
2019-07-19 19:46 UTC2019-07N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-206a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-201c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-209b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-203f0d92c62455…
2023-05-13 08:27 UTC2023-05N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-20053a50430f4f…
2023-01-26 05:58 UTC2023-01N021229-001PRILOSEC OTCEQ 20MG BASETABLET, DELAYED RELEASE / ORALRLD, RS2003-06-203bdfa0b2c4d7…

Observed Orange Book patent history#

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2019-12-13 00:20 UTC2019-12N021229-00164288102019-11-0374a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021229-00164036162019-11-1574a2ff9319b5…
2019-12-14 00:12 UTC2019-12N021229-00164288102019-11-033f01610625f2…
2019-12-14 00:12 UTC2019-12N021229-00164036162019-11-153f01610625f2…
2019-09-15 20:21 UTC2019-09N021229-00164288102019-11-03b00525d2431f…
2019-09-15 20:21 UTC2019-09N021229-00164036162019-11-15b00525d2431f…
2019-07-19 19:46 UTC2019-07N021229-00164288102019-11-03ea99ee380514…
2019-07-19 19:46 UTC2019-07N021229-00164036162019-11-15ea99ee380514…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Prilosec OTCOMEPRAZOLE MAGNESIUMThe Procter & Gamble Manufacturing Company77ed80a2-a482-4838-ac55-4865b5c31d9f2026-10-05WarningsExact identifier
ndc (product): 37000-455
3ab3af08-bbd8-4fe4-ba32-971374fe2b306ceb26ec-7ae4-45d5-96d1-82439273613b2011-06-20WarningsExact identifier
spl id: 3ab3af08-bbd8-4fe4-ba32-971374fe2b30
spl set id: 6ceb26ec-7ae4-45d5-96d1-82439273613b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.